TRENDING :  Market Movers  |  Top 50   SPY (-0.31%)    TSLA (-6.03%)    BYND (0.17%)    BTCUSD (%)    FTNT (-0.73%)    ELTK (-3.03%)    CANF (-7.48%)    ARQL (0.56%)    MCHP (-0.15%)    ONCS (-32.5%)    VXX (-0.95%)    IP (-1.4%)    INTC (-1.04%)    GTN (-1.44%)    GLW (0.1%)    ANY (-1.05%)    AMZN (0.12%)    AMPH (-1.4%)    ACAD (-1.57%)    ECOR (-13.74%)    DIS (-0.18%)    DFRG (1.48%)    CMG (-1.26%)    CGC (2.29%)    CCCL (-2.81%)

 AUPH - Aurinia Pharmaceuticals Inc

$6.49 [0.05][0.63%]

Next Earnings

8/8/2019

AMC

Recommend
Trade Idea »


ANALYST RATINGS

Quarterly Rating Chart
Rating

1


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $11.00
Low $11.00
Average $11.00
Current $6.49

CompanyAnalyst NamePT ActionActionRatingTargetDate
Raymond JamesRaisesMaintainsStrong Buy$11.0003/20/19
*Last 90 days

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $AUPH

Service NameTrader% Success
The Winning TraderStock Trader D60.00 %Subscribe
Symmetry OptionsSymmetry Options33.00 %Follow
BiotechnologyRobert Gadimian26.00 %Follow
cerevisiologyJohn Cho20.00 %Follow

TRENDING ARTICLES


Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss

05/14/19
Aurinia Pharmaceuticals AUPH came out with a quarterly loss of 0 16 per share in line with the Zacks Consensus Estimate This compares to loss of 0 18 per share a year ago These figures are adjusted for non recurring items A quarter ago it was expected that this biotechnology company

After-Hours Earnings Report for May 14, 2019 : A, DOX, NEWR, EGHT, AUPH, FSM, TCS, VCTR, OCX, PANL, REED, UQM

05/14/19
The following companies are expected to repor t earnings after hours on 05 14 2019 Visit our Earnings Calendar for a full list of expected earnings releases Agilent Technologies Inc A is reporting for the quarter ending April 30 2019 The

Aurinia Pharmaceuticals (AUPH) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

05/02/19
The market expects Aurinia Pharmaceuticals AUPH to deliver a year over year increase in earnings on higher revenues when i t report s results for the quarter ended March 2019 This widely known consensus outlook is important in assessing the company s earnings picture but a powerful factor